MBX — Microbix Biosystems Share News
0.000.00%
Last trade - 00:00- CA$43.74m
- CA$43.30m
- CA$18.59m
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million
Brief: Microbix Announces Initiation Of Normal Course Issuer Bid
Brief: Microbix Biosystems Q2 Gross Margin 60%
Brief: Microbix Biosystems - Products Exempt From U.S. Tariffs Under USMCA
Brief: Microbix Biosystems Inc Announces Repayment Of Mortgage Debt And Expansion Of Bank Line Of Credit
Brief: Microbix & BioGX Collaborate On Real-Time PCR Assays & Controls
Brief: Microbix Announces Initiation Of Normal Course Issuer Bid
Brief: Microbix Secures Funded Drug Commercialization Agreement
Brief: Microbix Reports Results For Q2 Fiscal 2023
Brief: Microbix Launches QAP To Support “Monkeypox” Testing
Brief: Microbix Biosystems Inc Announces Initiation Of Normal Course Issuer Bid
Brief: Microbix Biosystems executes substantial qaps supply agreement
Brief: Microbix Reports Record Results For Q2 Fiscal 2022
Brief: Microbix Invests To Further Scale Its Business
Brief: Microbix - Final Laboratory In Second Production Site, At 235 Watline Ave., Is Now Validated To Accommodate Automated And Larger-Scale Manufacturing
Brief: Microbix Launches Omicron Variant Test Control